• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    President & CEO Khaykin Oleg converted options into 367,500 shares and covered exercise/tax liability with 157,478 shares, increasing direct ownership by 14% to 1,701,068 units (SEC Form 4)

    3/4/25 3:50:22 PM ET
    $VIAV
    Semiconductors
    Technology
    Get the next $VIAV alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    KHAYKIN OLEG

    (Last) (First) (Middle)
    C/O VIAVI SOLUTIONS INC.
    1445 SOUTH SPECTRUM BLVD, SUITE 102

    (Street)
    CHANDLER AZ 85286

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    VIAVI SOLUTIONS INC. [ VIAV ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    President & CEO
    3. Date of Earliest Transaction (Month/Day/Year)
    02/28/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 02/28/2025 M 245,000(1) A $0 1,736,046 D
    Common Stock 02/28/2025 F 104,986(2) D $11.18 1,631,060 D
    Common Stock 03/01/2025 M 122,500(1) A $0 1,753,560 D
    Common Stock 03/01/2025 F 52,492(2) D $11.18 1,701,068 D
    Common Stock 118,914 I Held by reporting person's spouse
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units $0 02/28/2025 M 245,000 (3) (4) Common Stock 245,000 $0 0 D
    Performance Stock Units $0 03/01/2025 M 122,500 (5) (6) Common Stock 122,500 $0 0 D
    Explanation of Responses:
    1. Each stock unit converts upon vesting into one share of common stock.
    2. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award or performance stock award, as applicable. The amount retained by the Company was not in excess of the amount of the tax liability.
    3. Units subject to the Award shall vest on the four year anniversary of the grant date.
    4. There are no expiration dates on RSUs.
    5. Represents performance stock units for which the performance condition was determined by the Board to have been satisfied on December 12, 2022, which will vest in full on March 1, 2025, subject to the reporting person's continued service through the vesting date.
    6. There are no expiration dates on PSUs.
    /s/ Nandini Acharya, attorney-in-fact 03/04/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $VIAV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VIAV

    DatePrice TargetRatingAnalyst
    3/7/2025$14.00Neutral → Buy
    Rosenblatt
    1/31/2025$15.00Hold → Buy
    Needham
    12/17/2024$8.00 → $9.50Equal-Weight → Underweight
    Morgan Stanley
    11/19/2024$10.60Neutral
    UBS
    6/26/2024$8.25Buy → Neutral
    Rosenblatt
    5/3/2024$9.00Positive → Neutral
    Susquehanna
    2/12/2024$10.00 → $13.00Hold → Buy
    Stifel
    12/2/2022$12.00Hold
    Stifel
    More analyst ratings